Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.62 is 52% above its 5-year average of -1.29, near the high end of its 5-year range (-1.77–-0.62).
25.30% above its 12-month average of -0.83.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.11.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.62
EARNINGS PER SHARE (EPS) AVG TTM
-0.83
EARNINGS PER SHARE (EPS) AVG 3Y
-1.05
EARNINGS PER SHARE (EPS) AVG 5Y
-1.29
EARNINGS PER SHARE (EPS) AVG 10Y
-12.15
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+25.30%
CURRENT VS 3Y AVG
+40.95%
CURRENT VS 5Y AVG
+51.94%
CURRENT VS 10Y AVG
+94.90%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
aTyr Pharma, Inc.
Market Cap
$28.43M
Earnings Per Share (EPS)
-0.62
TTM Avg
-0.83
3Y Avg
-1.05
5Y Avg
-1.29
Market Cap
$27.31M
Earnings Per Share (EPS)
-4.31
TTM Avg
-4.75
3Y Avg
-350.99
5Y Avg
-43000.60
Market Cap
$30.65M
Earnings Per Share (EPS)
-3.21
TTM Avg
-2.50
3Y Avg
-4.25
5Y Avg
-9.67
Market Cap
$30.92M
Earnings Per Share (EPS)
-0.48
TTM Avg
-0.42
3Y Avg
-0.82
5Y Avg
-1.14
Market Cap
$31.36M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.24
3Y Avg
-0.01
5Y Avg
0.39
Market Cap
$25.48M
Earnings Per Share (EPS)
-0.29
TTM Avg
-0.41
3Y Avg
-1.95
5Y Avg
-2.99
Market Cap
$24.65M
Earnings Per Share (EPS)
N/A
TTM Avg
22.45
3Y Avg
9.70
5Y Avg
5.59
Market Cap
$32.31M
Earnings Per Share (EPS)
-2.56
TTM Avg
-5.45
3Y Avg
-15.27
5Y Avg
-9.79
Market Cap
$32.32M
Earnings Per Share (EPS)
-0.17
TTM Avg
-0.24
3Y Avg
-0.47
5Y Avg
-0.92
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| aTyr Pharma, Inc. (ATYR) | $28.43M | -0.62 | -0.83 | -1.05 | -1.29 |
| GridAI Technologies Corp. (GRDX)vs › | $27.31M | -4.31 | -4.75 | -350.99 | -43000.60 |
| CervoMed Inc. (CRVO)vs › | $30.65M | -3.21 | -2.50 | -4.25 | -9.67 |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | -0.48 | -0.42 | -0.82 | -1.14 |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | N/A | -0.24 | -0.01 | 0.39 |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | -0.29 | -0.41 | -1.95 | -2.99 |
| Kyntra Bio, Inc. (KYNB)vs › | $24.65M | N/A | 22.45 | 9.70 | 5.59 |
| EUDA Health Holdings Limited (EUDA)vs › | $32.31M | -2.56 | -5.45 | -15.27 | -9.79 |
| BeyondSpring Inc. (BYSI)vs › | $32.32M | -0.17 | -0.24 | -0.47 | -0.92 |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | -4.34 | -3.52 | -3.45 | -7.67 |
Trailing EPS (TTM)
$-0.62
Forward EPS (Est.)
$-0.45
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.80 |
| 2024-12-31 | -0.86 |
| 2023-12-31 | -0.94 |
| 2022-12-31 | -1.60 |
| 2021-12-31 | -1.77 |
| 2020-12-31 | -1.77 |
| 2019-12-31 | -7.03 |
| 2018-12-31 | -16.13 |
| 2017-12-31 | -26.16 |
| 2016-12-31 | -34.20 |
| 2015-12-31 | -42.42 |
| 2014-12-31 | -422.73 |
| 2013-12-31 | -429.90 |
| 2012-12-31 | -0.45 |
